Deoxyuridine as a surrogate marker of thymidylate synthase inhibition contributes to a multivariable model predicting 5-FU/LV response in metastatic colorectal cancer

Elisabeth Odin, Göran Carlsson, Bengt Gustavsson, Yvonne Wettergren

Open source

DOI
10.1016/j.ctarc.2025.101076
Published
2026
Container
Cancer Treatment and Research Communications
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ctarc.2025.101076,
  title = {Deoxyuridine as a surrogate marker of thymidylate synthase inhibition contributes to a multivariable model predicting 5-FU/LV response in metastatic colorectal cancer},
  author = {Elisabeth Odin and Göran Carlsson and Bengt Gustavsson and Yvonne Wettergren},
  year = {2026},
  journal = {Cancer Treatment and Research Communications},
  doi = {10.1016/j.ctarc.2025.101076},
  url = {https://doi.org/10.1016/j.ctarc.2025.101076}
}

RIS

TY  - JOUR
TI  - Deoxyuridine as a surrogate marker of thymidylate synthase inhibition contributes to a multivariable model predicting 5-FU/LV response in metastatic colorectal cancer
AU  - Elisabeth Odin
AU  - Göran Carlsson
AU  - Bengt Gustavsson
AU  - Yvonne Wettergren
PY  - 2026
JO  - Cancer Treatment and Research Communications
DO  - 10.1016/j.ctarc.2025.101076
UR  - https://doi.org/10.1016/j.ctarc.2025.101076
ER  - 

APA

Odin, E., Carlsson, G., Gustavsson, B., & Wettergren, Y. (2026). Deoxyuridine as a surrogate marker of thymidylate synthase inhibition contributes to a multivariable model predicting 5-FU/LV response in metastatic colorectal cancer. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2025.101076

Source records